Dapagliflozin in chronic kidney disease (CKD)

30th May 2022 by Louise Hudman

Dapagliflozin in chronic kidney disease (CKD)

This is new guidance from NICE advising that dapagliflozin can be used for certain patients with CKD. This was released in March 2022.

When can dapagliflozin be used to treat chronic kidney disease (CKD)?

It can be used for treating CKD in adults. It can be used for the following patients.

  • Patients should be on optimised doses of ACE inhibitor (ACEi) or Angiotensin II receptor blockers (A2RBs) (unless contraindicated) before adding on dapagliflozin AND
    • Have an eGFR of 25 to 75 at the start of treatment AND
      • Have T2DM with any albumin-to-creatinine ratio (ACR) OR
        • Have ACR of 22.6 mg/mmol or more if they don’t have type 2 diabetes mellitus (T2DM).

Can GPs prescribe dapagliflozin for patients without diabetes?

Yes, patients without T2DM can, as long as their ACR is above 22.6.

Read more

No credit card details needed – it takes two minutes.

Join free trial


Already a member? Login to view this content.


Related content

"LocumDeck is easy to use and straightforward."

Claire Farragher, Practice Manager, Regent Street Surgery, Stonehouse, Gloucestershire

See the full list of features within our NASGP membership plans